A.R.T. Advisors’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-12,600
Closed -$225K 1893
2017
Q2
$225K Buy
+12,600
New +$235K 0.01% 1116
2016
Q3
Sell
-29,425
Closed -$588K 1478
2016
Q2
$588K Buy
29,425
+18,000
+158% +$336K 0.03% 750
2016
Q1
$193K Buy
+11,425
New +$234K 0.01% 1179
2015
Q2
Sell
-13,603
Closed -$186K 1863
2015
Q1
$186K Sell
13,603
-8,989
-40% -$104K 0.01% 1249
2014
Q4
$238K Buy
22,592
+4,521
+25% +$53.5K 0.01% 1178
2014
Q3
$225K Buy
18,071
+1,943
+12% +$27.1K 0.01% 1049
2014
Q2
$220K Sell
16,128
-2,397
-13% -$31.3K 0.01% 1092
2014
Q1
$223K Buy
18,525
+958
+5% +$11K 0.01% 1118
2013
Q4
$215K Buy
+17,567
New +$206K 0.01% 1092

Other funds holding OME

A.R.T. Advisors's OME Position: Q3 2017 in Review

A.R.T. Advisors sold out of Omega Protein (OME) in Q3 2017, closing a stake of 12,600 shares — an estimated $225K sold.

A.R.T. Advisors first reported a position in OME in Q4 2013 and held it in 9 quarters. The position peaked at $588K in Q2 2016. 122 funds tracked by Wall St. Rank hold OME as of Q3 2017.

  • A.R.T. Advisors reported no remaining Omega Protein position as of Q3 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 12,600 Omega Protein shares in Q3 2017, an estimated $225K.
  • A.R.T. Advisors first reported a position in Omega Protein in Q4 2013 and held it in 9 quarters.
  • A.R.T. Advisors's Omega Protein position peaked at $588K in Q2 2016.
  • 122 funds tracked by Wall St. Rank held Omega Protein as of Q3 2017.

Based on A.R.T. Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.